GlassScriptPhysician profile
Christopher Thomas Martin
NPI 1710272042
$130,971.75
in general payments reported to CMS, 2019-2025
9 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,078 · 2020: $22.25 · 2021: $2,146 · 2022: $25K · 2023: $30K · 2024: $32K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $79K · Travel and Lodging: $20K · Food and Beverage: $3,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $78,700.00 |
| Travel and Lodging | $19,910.82 |
| Food and Beverage | $3,922.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $109,680.09 | 2021-2025 | Infinity Occipitocervical Upper Thoracic System, Catalyft Pl Expandable Interbody System, Endoskeleton Tc Nanolock Surface Technology |
| Alphatec Spine, INC | $9,354.42 | 2021-2025 | Other - Miscellaneous, Solus Alif |
| Si-Bone, INC. | $6,538.33 | 2024-2025 | |
| Providence Medical Technology, INC. | $1,592.45 | 2025 | |
| Smaio Sa | $1,372.38 | 2023 | |
| Medtronic USA, INC. | $1,100.65 | 2019-2020 | |
| Foundation Medical, LLC | $903.00 | 2025 | |
| Arthrex, INC. | $288.20 | 2025 | |
| Zimmer Biomet Holdings, INC. | $142.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.